HLB Therapeutics Co.,Ltd.
Develops innovative drugs for rare eye diseases and brain tumors, with vaccine logistics.
115450 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 분당구 정자일로 248, 성남시
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
HLB Therapeutics Co., Ltd. is a biopharmaceutical company specializing in the development of innovative, first-in-class drugs for rare and intractable diseases. The company's core focus is on its clinical pipeline, which includes RGN-259, a therapeutic candidate for ophthalmic conditions such as Neurotrophic Keratopathy and Dry Eye Disease, and OKN-007 for treating Glioblastoma Multiforme. In addition to its primary research and development activities, the company has diversified business areas that include vaccine distribution and cold chain logistics.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for HLB Therapeutics Co.,Ltd. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
Automate Your Workflow. Get a real-time feed of all HLB Therapeutics Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for HLB Therapeutics Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
